Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Serine Peptidase Inhibitor Kazal-Type 5 MeSH Descriptor Data 2025


MeSH Heading
Serine Peptidase Inhibitor Kazal-Type 5
Tree Number(s)
D12.644.822.750.250
D12.776.815.688.250
Unique ID
D000074163
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000074163
Scope Note
A secreted serine peptidase inhibitor that consists of 15 KAZAL MOTIFS and inhibits KALLIKREINS KLK5, KLK7, and KLK14 as well as TRYPSIN. It plays important roles in protecting MUCOSA against infection and inflammation, and in maintaining the integrity of the skin. Mutations in the SPINK5 gene are associated with NETHERTON SYNDROME.
Entry Term(s)
LEKTI Protein
Lympho-Epithelial Kazal-Type Inhibitor
SPINK5 Protein
Serine Protease Inhibitor Kazal-Type 5
Registry Numbers
0
Previous Indexing
Carrier Proteins (1999-2017)
Proteinase Inhibitory Proteins, Secretory (2005-2017)
See Also
Kazal Motifs
Netherton Syndrome
Public MeSH Note
2018
History Note
2018
Date Established
2018/01/01
Date of Entry
2017/07/11
Revision Date
2022/07/12
Serine Peptidase Inhibitor Kazal-Type 5 Preferred
page delivered in 0.146s